The current standard of care for the surgical management of invasive breast cancer is the complete ... 1 patient had skip metastasis. Blue dye identified SLNs in 533 (76.1%) of 665 patients ...
The findings, published in Cell, provide the first evidence of genetic predisposition to breast cancer metastasis, with far-reaching clinical implications-;including a potential therapy that could ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback